Topline phase 3 TRIUMPH-2 and TRIUMPH-3 trial data show robust weight loss and improved glycemic control with retatrutide in adults with T2D, obesity, and CVD.
Among adults with prediabetes, lifestyle intervention, but not metformin, was associated with a lower burden of multimorbidity during 21 years of follow-up, which highlights the importance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results